-
1
المؤلفون: Frank Winkler, Wolfgang Wick, Matthias Preusser, Louisa von Baumgarten, Frits Thorsen, Pablo Perez-Moreno, Stefanie Srock, Viktor Nendel, Beatrix Lutiger, Luca Gianni, Paola Mariani, David Miles, Martin Reck, Miriam Gömmel, Yunxiang Liao, Matthias Osswald, Aysegül Ilhan-Mutlu
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36113c38c7a5884ce55a2ac6b5d91237
https://doi.org/10.1158/1535-7163.22508143.v1 -
2
المؤلفون: Frank Winkler, Wolfgang Wick, Matthias Preusser, Louisa von Baumgarten, Frits Thorsen, Pablo Perez-Moreno, Stefanie Srock, Viktor Nendel, Beatrix Lutiger, Luca Gianni, Paola Mariani, David Miles, Martin Reck, Miriam Gömmel, Yunxiang Liao, Matthias Osswald, Aysegül Ilhan-Mutlu
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb8274edfe2e4fc736b75b78e544e7b7
https://doi.org/10.1158/1535-7163.22508137 -
3
المؤلفون: Frank Winkler, Wolfgang Wick, Matthias Preusser, Louisa von Baumgarten, Frits Thorsen, Pablo Perez-Moreno, Stefanie Srock, Viktor Nendel, Beatrix Lutiger, Luca Gianni, Paola Mariani, David Miles, Martin Reck, Miriam Gömmel, Yunxiang Liao, Matthias Osswald, Aysegül Ilhan-Mutlu
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0674a273da584857097f58b30a51cd27
https://doi.org/10.1158/1535-7163.22508140.v1 -
4
المؤلفون: Pablo Perez-Moreno, Luca Gianni, Martin Reck, Miriam Gömmel, Viktor Nendel, Paola Mariani, David Miles, Matthias Preusser, Aysegül Ilhan-Mutlu, Wolfgang Wick, Matthias Osswald, Frank Winkler, Yunxiang Liao, Stefanie Srock, Louisa von Baumgarten, Beatrix Lutiger, Frits Thorsen
المصدر: Molecular Cancer Therapeutics. 15:702-710
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, Adenocarcinoma of Lung, Angiogenesis Inhibitors, Antineoplastic Agents, Adenocarcinoma, Neovascularization, Mice, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Cell Line, Tumor, Internal medicine, medicine, Animals, Humans, Multicenter Studies as Topic, Stage (cooking), Neoplasm Staging, Randomized Controlled Trials as Topic, Retrospective Studies, Lung, Neovascularization, Pathologic, Brain Neoplasms, business.industry, Incidence, Cancer, medicine.disease, Xenograft Model Antitumor Assays, Clinical trial, Disease Models, Animal, 030104 developmental biology, medicine.anatomical_structure, Clinical Trials, Phase III as Topic, 030220 oncology & carcinogenesis, Neoplasm Recurrence, Local, medicine.symptom, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50f763ddfeef9f279070e50d477021e8
https://doi.org/10.1158/1535-7163.mct-15-0582 -
5
المؤلفون: Eduard Vrdoljak, Christoph C. Zielinski, Cristian Villanueva, Joseph Gligorov, Fabio Puglisi, Ulrich Freudensprung, Sabine de Ducla, Gilles Romieu, Javier Cortes, Stefanie Srock, Michelino De Laurentiis, Gunter von Minckwitz, Corinne Veyret, István Láng, Eva Ciruelos, Norbert Marschner
المساهمون: von Minckwitz, Gunter, Puglisi, Fabio, Cortes, Javier, Vrdoljak, Eduard, Marschner, Norbert, Zielinski, Christoph, Villanueva, Cristian, Romieu, Gille, Lang, István, Ciruelos, Eva, DE LAURENTIIS, Michelino, Veyret, Corinne, de Ducla, Sabine, Freudensprung, Ulrich, Srock, Stefanie, Gligorov, Joseph
المصدر: The Lancet Oncology. 15:1269-1278
مصطلحات موضوعية: Oncology, Time Factors, genetic structures, medicine.medical_treatment, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, genetics, skin and connective tissue diseases, Humanized, education.field_of_study, Medicine (all), drug therapy/genetics/mortality/pathology, Remission Induction, Middle Aged, Metastatic breast cancer, Bevacizumab, Treatment Outcome, Local, Retreatment, metastatic breast cancer, Drug, medicine.drug, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Combination therapy, Population, Breast Neoplasms, Antibodies, Monoclonal, Humanized, administration /&/ dosage/adverse effects, Antibodies, Disease-Free Survival, Drug Administration Schedule, methods, Dose-Response Relationship, Breast cancer, Internal medicine, medicine, Humans, Neoplasm Invasiveness, education, Survival analysis, Aged, erbB-2, drug therapy/mortality/pathology, Neoplasm Staging, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Patient Selection, Genes, erbB-2, medicine.disease, Survival Analysis, eye diseases, Neoplasm Recurrence, Genes, pathology, sense organs, Neoplasm Recurrence, Local, business, Adult, Aged, Antibodies, administration /&/ dosage/adverse effects, Antineoplastic Combined Chemotherapy Protocols, administration /&/ dosage/adverse effects, Breast Neoplasms, drug therapy/genetics/mortality/pathology, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, Follow-Up Studies, Genes, genetics, Humans, Maximum Tolerated Dose, Middle Aged, Neoplasm Invasiveness, pathology, Neoplasm Recurrence, drug therapy/mortality/pathology, Neoplasm Staging, Patient Selection, Remission Induction, methods, Retreatment, Survival Analysis, Time Factors, Treatment Outcome, Follow-Up Studies
-
6
المؤلفون: Peter O'Dwyer, J. Tabernero, Ivan Bosanac, Christoph Mancao, A. de Gramont, Dirk Arnold, Stefanie Srock, J. Winter, H.-J. Schmoll, E. Van Cutsem, F. Gilberg, A. Grothey, Michel Ducreux
المصدر: Annals of Oncology. 29:viii714-viii715
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Bevacizumab, Colorectal cancer, medicine.medical_treatment, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Atezolizumab, law, Internal medicine, Induction therapy, medicine, Neoadjuvant therapy, business.industry, Hematology, medicine.disease, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, Biomarker (medicine), business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4df8c5d01daf35b367a690268c27572d
https://doi.org/10.1093/annonc/mdy424.020 -
7
المؤلفون: José Bines, Dinesh Doval, Romulo Costa, Sabine de Ducla, Paulo Cortes, Giorgio Mustacchi, Joseph Gligorov, Emilio Alba, Ulrich Freudensprung, Stefanie Srock, Jean-Yves Pierga, Vineet Govinda Gupta
المساهمون: Joseph, Gligorov, Dinesh, Doval, José, Bine, Emilio, Alba, Paulo, Corte, Jean Yves, Pierga, Vineet, Gupta, Rômulo, Costa, Stefanie, Srock, Sabine de, Ducla, Ulrich, Freudensprung, Mustacchi, Giorgio
مصطلحات موضوعية: Adult, Oncology, China, medicine.medical_specialty, genetic structures, Bevacizumab, Receptor, ErbB-2, Population, Breast Neoplasms, Docetaxel, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, Deoxycytidine, Disease-Free Survival, Capecitabine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, breast, ca, education, Aged, Aged, 80 and over, education.field_of_study, business.industry, Hazard ratio, Middle Aged, medicine.disease, Metastatic breast cancer, eye diseases, Fluorouracil, Female, Taxoids, business, medicine.drug
وصف الملف: STAMPA
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a65791d79ca13f2ee6f2c264d59f78a2
https://hdl.handle.net/11368/2827331 -
8
المؤلفون: Dirk Arnold, Axel Grothey, Leonard B. Saltz, Heinz-Josef Lenz, Herbert Hurwitz, Linda Yau, Jonathan Talbot, Quynh Lan Nguyen, Stefanie Srock, Fotios Loupakis, S. Osborne
المصدر: Journal of Clinical Oncology. 36:726-726
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, Prognostic factor, Bevacizumab, business.industry, Colorectal cancer, medicine.medical_treatment, medicine.disease, Primary tumor, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Tumor location, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b19dad7763339eb923f4e05b07c0abf1
https://doi.org/10.1200/jco.2018.36.4_suppl.726 -
9
المؤلفون: Sabine Neser, Antje Haas, Ralph Naumann, Erika Kettner, Robert Rohrberg, Kathrin Haifa Al-Ali, Ursula Haak, Michael Herold, Christian Klinkenstein, Astrid Franke, Mathias Freund, Gottfried Dölken, Ulrich Mey, Ullrich von Grünhagen, Michael Aβmann, Klaus Höffken, Stefanie Srock, Wolfgang Knauf, Thomas Ittel, Andreas Neubauer
المصدر: Journal of Clinical Oncology. 25:1986-1992
مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Adolescent, Prednisolone, Population, Follicular lymphoma, Alpha interferon, Interferon alpha-2, Antibodies, Monoclonal, Murine-Derived, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Lymphoma, Follicular, Aged, Aged, 80 and over, education.field_of_study, Mitoxantrone, Chlorambucil, business.industry, Antibodies, Monoclonal, Interferon-alpha, Middle Aged, Prognosis, medicine.disease, Recombinant Proteins, Survival Rate, Treatment Outcome, Female, Mantle cell lymphoma, Rituximab, Refractory Follicular Lymphoma, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba5a75ad1f7f18a4a63fcdb50a725f2a
https://doi.org/10.1200/jco.2006.06.4618 -
10
المؤلفون: Antonio Pezzutto, Norbert Avril, B. I. Humplik, D. L. Munz, Thomas Kroessin, Ingrid Reisinger, Christel Reim, Maren Bienert, Stefanie Srock
المصدر: European Journal of Nuclear Medicine and Molecular Imaging. 32:1225-1233
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Lymphoma, B-Cell, medicine.medical_treatment, Pilot Projects, Severity of Illness Index, Gastroenterology, Antibodies, Monoclonal, Murine-Derived, Autologous stem-cell transplantation, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Radiation Injuries, Adverse effect, Aged, Chemotherapy, business.industry, Antibodies, Monoclonal, General Medicine, Middle Aged, Radioimmunotherapy, medicine.disease, Lymphoma, Non-Hodgkin's lymphoma, Treatment Outcome, Monoclonal, Immunology, Female, Rituximab, Neoplasm Recurrence, Local, Radiopharmaceuticals, business, medicine.drug